1 Coapplication experiments reveal competitive-like functi
2 GABA responses were unaffected when
coapplication lasted only 2 ms.
3 Coapplication of 0.1 to 1% (17-170 mM) ethanol influence
4 In contrast, the
coapplication of 10 microM MK-801 and 300 microM GYKI-52
5 Coapplication of 10(-6) m RPCH and 10(-6) m CabTRP elici
6 Coapplication of 10-100 microM cyclothiazide with glutam
7 ta3gamma2 cDNAs was greatly decreased by the
coapplication of 100 microM LaCl3.
8 ions and that this effect was neutralized by
coapplication of 17-PA with 3alpha5alphaP.
9 We also show that 20 nm TTX or
coapplication of 20 microm RIL + FFA (100-200 microm) st
10 ean +/- S.D.) 7.7 +/- 5% to 192 +/- 52% upon
coapplication of 3 to 300 mM ethanol with 1 to 3 microM
11 C, K53C, and S54C) of 23 functional mutants,
coapplication of 30 microm ATP and 500 nm Ag(+) irrevers
12 Coapplication of 50 muM PYD-106 with a maximally effecti
13 These enhancing effects were reversed by
coapplication of a alpha4beta2-nAChR antagonist, consist
14 Strong activation of PKA in the nerve by
coapplication of a membrane-permeant analog of cAMP and
15 Coapplication of a pharmacologic chaperone and a proteos
16 The
coapplication of a Y5 but not Y1 receptor antagonist eli
17 In addition,
coapplication of ACh and 4BP-TQS results in a further in
18 Conversely,
coapplication of adenosine (10(-6) M) attenuated NMDA re
19 eceptor desensitization was inhibited by the
coapplication of AMPA and cyclothiazide or by the use of
20 Coapplication of an antagonist of metabotropic glutamate
21 autaptic EPSCs was effectively abolished by
coapplication of an antibody to synaptotagmin-1 C2B doma
22 hough typical PAMs, like PNU-120596, require
coapplication of an orthosteric agonist to produce large
23 We have shown that intranasal
coapplication of Bacillus anthracis protective Ag (PA) t
24 restored after baclofen treatment by either
coapplication of baclofen and adenosine, or intracellula
25 GABA(A) receptor antagonist bicuculline, and
coapplication of bicuculline and DNQX fully abolished th
26 Coapplication of bisindolylmaleimide V, used as a negati
27 Coapplication of bupropion or hydroxybupropion with 5-HT
28 Importantly,
coapplication of diazoxide and CsA exhibited additive ef
29 However, on
coapplication of dopamine reuptake inhibitors with nicot
30 Coapplication of dopamine, however, shows no facilitatin
31 depression could be transformed into LTD by
coapplication of dopamine.
32 Furthermore,
coapplication of Eeyarestatin I and suberanilohydroxamic
33 Coapplication of either 5 microM AMPA or 500 microM aspa
34 Coapplication of either GABA or the competitive antagoni
35 Coapplication of ethanol further increased the ghrelin-i
36 oncentrations of ACh also was increased upon
coapplication of ethanol.
37 Coapplication of EU1794-4 with a maximally effective con
38 The
coapplication of exogenous exendin-4 and, specifically,
39 f alpha1beta2gamma2L GABA-A receptors during
coapplication of GABA and an endogenous neurosteroid (3a
40 ho1A subunit, terminating simultaneously the
coapplication of GABA and picrotoxin induced a large reb
41 Coapplication of GABA or muscimol, but not of gabazine,
42 rate-induced rate change (i) is prevented by
coapplication of GAT1 antagonists, (ii) does not occur i
43 ons of phalloidin and actin were reversed by
coapplication of gelsolin and cytochalasin D, respective
44 e to NPY and any aftereffect were blocked by
coapplication of glutamate receptor antagonists.
45 d not enhance ISO-induced increases in cAMP,
coapplication of ISO and carbachol synergistically activ
46 ression of synaptic transmission elicited by
coapplication of Iso and DCG-IV, while having no signifi
47 Coapplication of kynurenate with glutamate to heteromeri
48 plication of L-732,138, and fully blocked by
coapplication of L-732,138 and SB222200 (an NK3 receptor
49 A brief
coapplication of L-glutamate and MK-801 resulted in a bl
50 Coapplication of low concentrations of DAMGO did not inc
51 In rat hippocampal slices,
coapplication of LY487379 potentiated synaptically evoke
52 of cross-presentation by Ig was inhibited by
coapplication of mannan and, thus, likely to be mediated
53 No further depolarization was seen with
coapplication of maximal glutamate during the maximal iv
54 In cell-pelleting ischemia assays,
coapplication of MCC-134 with diazoxide abolished the ca
55 urrent was rapidly and reversibly blocked by
coapplication of mecamylamine and d-tubocurarine.
56 Coapplication of memantine was associated with recovery
57 Coapplication of menthol with acetylcholine or nicotine
58 We conclude that
coapplication of metformin enhances the glucose-lowering
59 Furthermore, topical
coapplication of MMP13i with gatifloxacin greatly improv
60 We found that
coapplication of NMDA and the mGluR5 agonist (S)-3,5-dih
61 2 was abolished when recycling was halted by
coapplication of nocodazole and latrunculin-A.
62 The NMDA-induced phase delay was blocked by
coapplication of NPY (0.02-200 microm).
63 Coapplication of pentobarbital, benzodiazepines, and zol
64 versible, are stereospecific, are blocked by
coapplication of PKC inhibitors, and closely match those
65 Coapplication of representative blockers and openers rev
66 2) and tissue analysis of ATP, we found that
coapplication of rotenone (50 nM), a mitochondrial compl
67 Strikingly,
coapplication of rotenone and succinate also prevented g
68 Coapplication of serine protease inhibitors with the sup
69 versed in the two neuronal subclasses by the
coapplication of the appropriate combination of pharmaco
70 Here we show that temporary
coapplication of the cyclic resveratrol trimer carapheno
71 Coapplication of the two agonists at their EC(50) concen
72 BDNF's effects were abolished by
coapplication of the tyrosine kinase inhibitor K252a.
73 Experiments involving
coapplication of two or more steroids revealed that the
74 In vivo,
coapplication of UV-inactivated MV with NDV led to incre
75 d in the pain model but could be restored by
coapplication of VU0360172 and ACEA.
76 Moreover,
coapplication of Z-VAD-FMK and nifedipine produced virtu
77 apable of opening nonconductive channels and
coapplication of zinc pyrithione and retigabine could re
78 Coapplication of zinc with low concentrations of acetylc
79 stratum corneum, effects largely reversed by
coapplications of cholesterol.
80 Coapplications of n-octanol increased peak currents evok
81 This strategy, termed
coapplication reverse transcription (Co-RT), allows for
82 However, results of
coapplication studies and the apparent lack of state dep
83 Coapplication with a nonselective glutamate or lactate t
84 Coapplication with ACh enhanced the extent of MTS modifi
85 spase-3 activity, which could be reversed by
coapplication with endothelin-1, bFGF, or the adenylate
86 w onset of Con G block could be prevented by
coapplication with high concentrations of NMDA or of the
87 Agonist
coapplication with MTSET reduced the extent and rate of
88 SEA sensitivity was significantly amended by
coapplication with substrates.
89 llosteric activity was nearly abolished upon
coapplication with the AA site-selective antagonist 2,3,